查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607194

葡萄糖胺市场：按类型、形式、来源、应用和分销管道划分 - 全球预测 2025-2030

Glucosamine Market by Types (Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride), Form (Capsules, Liquid, Powder), Source, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年葡萄糖胺市场价值为8.048亿美元，预计2024年将达到8.4171亿美元，复合年增长率为5.28%，到2030年将达到11.4762亿美元。

葡萄糖胺是一种对软骨发育至关重要的天然化合物，因其在关节健康中的作用而被广泛认可，并且经常用于旨在治疗骨关节炎和其他关节相关疾病的补充品中。老化社会、运动员和注重健康的人们对肌肉骨骼健康的认识不断提高，正在扩大市场基础。推动葡萄糖胺需求的主要需求是其缓解关节疼痛和提高运动表现的潜力，这使其在製药、食品和食品补充品行业中受到高度重视。其应用范围扩展到动物健康，具有广泛的最终用途，包括帮助解决宠物的类似问题。影响成长的主要趋势包括预防保健的趋势、补充品使用的增加以及支持葡萄糖胺益处的持续研究。将葡萄糖胺与软骨素和 MSM 融合的组合​​补充品等配方创新带来了巨大的机会，而意识和健康支出不断上升的开拓区域市场也是如此。挑战也依然存在，包括对葡萄糖胺产品功效的担忧、替代疗法等竞争动态以及食品领域的监管审查。在永续性问题的背景下，公司必须应对这些挑战，以及由于海鲜和贝类来源而导致的原材料价格波动。未来的市场扩张可能会受到输送机制创新的推动，例如透过液化来增加吸收，以及透过纯素或合成葡萄糖胺来迎合素食市场。此外，强烈建议相关人员加强临床测试以支持科学主张，以巩固其市场地位。整体市场格局多样化且竞争激烈，这使得策略联盟和消费者教育成为最大程度地发挥市场格局成长潜力并应对挑战的重要工具。

主要市场统计
基准年[2023] 80048万美元
预测年份 [2024] 84171万美元
预测年份 [2030] 1,147.62 百万美元
复合年增长率（%） 5.28%

市场动态：揭示快速发展的葡萄糖胺市场的关键市场洞察

供需的动态交互作用正在改变葡萄糖胺市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 肥胖人口增加和关节炎患者增加
    • 骨骼和关节保健补充品中葡萄糖胺的使用增加
    • 治疗有症状的膝骨关节炎对葡萄糖胺的需求不断增长
  • 市场限制因素
    • 与葡萄糖胺产品相关的高成本
  • 市场机会
    • 葡萄糖胺新产品的上市与核准
    • 製造商专注于葡萄糖胺领域的研发活动
  • 市场问题
    • 与葡萄糖胺相关的一些副作用

波特的五力：驾驭葡萄糖胺市场的策略工具

波特的五力框架是了解葡萄糖胺市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解葡萄糖胺市场的外部影响

外部宏观环境因素在塑造葡萄糖胺市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解葡萄糖胺市场的竞争格局

对葡萄糖胺市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：葡萄糖胺市场供应商的绩效评估

FPNV定位矩阵是评估葡萄糖胺市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製葡萄糖胺市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对葡萄糖胺市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3. 塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肥胖人口增加和关节炎患者数量增加
      • 骨骼和关节保健补充品中葡萄糖胺的使用增加
      • 治疗有症状的膝骨关节炎时对葡萄糖胺的需求不断增加
    • 抑制因素
      • 与葡萄糖胺产品相关的高成本
    • 机会
      • 葡萄糖胺新产品的上市与核准
      • 製造商专注于葡萄糖胺领域的研发活动
    • 任务
      • 与葡萄糖胺相关的一些副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章葡萄糖胺市场：依类型

  • 介绍
  • 盐酸盐葡萄糖胺
  • 葡萄糖胺硫酸盐氯化钾
  • 葡萄糖胺硫酸盐氯化钠
  • N-乙酰葡萄糖胺

第七章 葡萄糖胺市场：依形式

  • 介绍
  • 胶囊
  • 液体
  • 粉末
  • 锭剂

第八章葡萄糖胺市场：依来源分类

  • 介绍
  • 动物
    • 螃蟹
    • 龙虾
    • 虾
  • 植物
    • 玉米
    • 菇

第九章葡萄糖胺市场：依应用分类

  • 介绍
  • 化妆品
  • 食品补充品
  • 保健食品
  • 药品
  • 兽医

第10章葡萄糖胺市场：按分销管道

  • 介绍
  • 网路商店
  • 药局
  • 零售店
  • 超级市场

第十一章美洲葡萄糖胺市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太葡萄糖胺市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的葡萄糖胺市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aden Healthcare
  • Andra Medi Pharma India Pvt. Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Captek Softgel International Inc.
  • Cargill, Inc.
  • Cellmark AB
  • Enomark Pharma
  • Ethical Naturals Inc.
  • Fabrichem, Inc.
  • Fermentis Life Sciences
  • GlucosaGreen
  • Golden Shell Pharmaceutical Co. Ltd.
  • Kabir Lifesciences
  • Koyo Chemical Co., Ltd.
  • Lifecare Neuro Products Limited
  • Manus Aktteva Biopharma LLP
  • Panvo Organics Pvt Ltd.
  • Pax Healthcare
  • Schiff Nutrition International Inc.
  • SMPNutra
  • Spectrum Chemical Manufacturing Corp.
  • TSI Health Sciences, Inc.
  • United Laboratories, Inc.
  • Velnex Medicare
  • Wellable Marine BIoTech Holding Limited
  • Zhejiang AOXING BIoTechnology Co., Ltd.
Product Code: MRR-C002B1C994F7

The Glucosamine Market was valued at USD 800.48 million in 2023, expected to reach USD 841.71 million in 2024, and is projected to grow at a CAGR of 5.28%, to USD 1,147.62 million by 2030.

Glucosamine, a natural compound integral to cartilage development, is widely recognized for its role in joint health and often sourced for supplements aimed at managing osteoarthritis and other joint-related ailments. The growing awareness of musculoskeletal health among aging populations, athletes, and health-conscious individuals has expanded the market's reach. A major necessity driving glucosamine demand is its potential to alleviate joint pain and improve mobility, largely appreciated in pharmaceutical, nutraceutical, and food supplements industries. Its application extends to animal health, where it's incorporated to aid similar issues in pets, marking a varied end-use scope. Key factors influencing growth include the trend towards preventive healthcare, an increase in supplement usage, and ongoing research corroborating glucosamine's benefits. Innovations in formulation, such as combination supplements merging glucosamine with chondroitin or MSM, pose substantial opportunities, as do unexplored regional markets where awareness and health expenditure are on the rise. Nevertheless, challenges persist: concerns regarding the efficacy of glucosamine products, competitive dynamics involving alternative therapies, and regulatory scrutiny in the nutraceutical space. Companies must navigate these issues alongside fluctuating raw material prices due to its marine and shellfish origins, against the backdrop of sustainability concerns. Future market expansion can be fueled by innovation in delivery mechanisms, such as liquid form for enhanced absorption and vegan or synthetic glucosamine to cater to vegetarian demographics. Additionally, enhancing clinical trials to reinforce scientific claims serves as a strong recommendation for stakeholders to consolidate market positions. The overall market landscape is diverse and competitive, with strategic alliances and consumer education emerging as critical tools to leverage glucosamine's full growth potential while addressing prevailing market challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 800.48 million
Estimated Year [2024] USD 841.71 million
Forecast Year [2030] USD 1,147.62 million
CAGR (%) 5.28%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Glucosamine Market

The Glucosamine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing obese population coupled with increasing number of arthritis cases
    • Increasing use of glucosamine in bone and joint health supplements
    • Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
  • Market Restraints
    • High cost related to glucosamine products
  • Market Opportunities
    • Launch and approval of novel glucosamine products
    • Focus of manufacturers on R&D activities in the field of glucosamine
  • Market Challenges
    • Several side effects associated with glucosamine

Porter's Five Forces: A Strategic Tool for Navigating the Glucosamine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Glucosamine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Glucosamine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Glucosamine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Glucosamine Market

A detailed market share analysis in the Glucosamine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Glucosamine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Glucosamine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Glucosamine Market

A strategic analysis of the Glucosamine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co. Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Types, market is studied across Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride, Glucosamine Sulfate Sodium Chloride, and N-Acetylglucosamine.
  • Based on Form, market is studied across Capsules, Liquid, Powder, and Tablets.
  • Based on Source, market is studied across Animal and Plant. The Animal is further studied across Crab, Lobster, and Shrimp. The Plant is further studied across Corn and Mushrooom.
  • Based on Application, market is studied across Cosmetics, Dietary Supplements, Health Food, Medicine, and Veterinary.
  • Based on Distribution Channel, market is studied across Online Stores, Pharmacies, Retail Stores, and Supermarkets.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing obese population coupled with increasing number of arthritis cases
      • 5.1.1.2. Increasing use of glucosamine in bone and joint health supplements
      • 5.1.1.3. Rising need for glucosamine for the treatment of symptomatic osteoarthritis of the knee
    • 5.1.2. Restraints
      • 5.1.2.1. High cost related to glucosamine products
    • 5.1.3. Opportunities
      • 5.1.3.1. Launch and approval of novel glucosamine products
      • 5.1.3.2. Focus of manufacturers on R&D activities in the field of glucosamine
    • 5.1.4. Challenges
      • 5.1.4.1. Several side effects associated with glucosamine
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Glucosamine Market, by Types

  • 6.1. Introduction
  • 6.2. Glucosamine Hydrochloride
  • 6.3. Glucosamine Sulfate Potassium Chloride
  • 6.4. Glucosamine Sulfate Sodium Chloride
  • 6.5. N-Acetylglucosamine

7. Glucosamine Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Liquid
  • 7.4. Powder
  • 7.5. Tablets

8. Glucosamine Market, by Source

  • 8.1. Introduction
  • 8.2. Animal
    • 8.2.1. Crab
    • 8.2.2. Lobster
    • 8.2.3. Shrimp
  • 8.3. Plant
    • 8.3.1. Corn
    • 8.3.2. Mushrooom

9. Glucosamine Market, by Application

  • 9.1. Introduction
  • 9.2. Cosmetics
  • 9.3. Dietary Supplements
  • 9.4. Health Food
  • 9.5. Medicine
  • 9.6. Veterinary

10. Glucosamine Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Online Stores
  • 10.3. Pharmacies
  • 10.4. Retail Stores
  • 10.5. Supermarkets

11. Americas Glucosamine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Glucosamine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Glucosamine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aden Healthcare
  • 2. Andra Medi Pharma India Pvt. Ltd.
  • 3. Bio-gen Extracts Pvt. Ltd.
  • 4. Captek Softgel International Inc.
  • 5. Cargill, Inc.
  • 6. Cellmark AB
  • 7. Enomark Pharma
  • 8. Ethical Naturals Inc.
  • 9. Fabrichem, Inc.
  • 10. Fermentis Life Sciences
  • 11. GlucosaGreen
  • 12. Golden Shell Pharmaceutical Co. Ltd.
  • 13. Kabir Lifesciences
  • 14. Koyo Chemical Co., Ltd.
  • 15. Lifecare Neuro Products Limited
  • 16. Manus Aktteva Biopharma LLP
  • 17. Panvo Organics Pvt Ltd.
  • 18. Pax Healthcare
  • 19. Schiff Nutrition International Inc.
  • 20. SMPNutra
  • 21. Spectrum Chemical Manufacturing Corp.
  • 22. TSI Health Sciences, Inc.
  • 23. United Laboratories, Inc.
  • 24. Velnex Medicare
  • 25. Wellable Marine Biotech Holding Limited
  • 26. Zhejiang AOXING Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLUCOSAMINE MARKET RESEARCH PROCESS
  • FIGURE 2. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLUCOSAMINE MARKET DYNAMICS
  • TABLE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE POTASSIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE SODIUM CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY N-ACETYLGLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GLUCOSAMINE MARKET SIZE, BY CRAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GLUCOSAMINE MARKET SIZE, BY LOBSTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GLUCOSAMINE MARKET SIZE, BY SHRIMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GLUCOSAMINE MARKET SIZE, BY CORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GLUCOSAMINE MARKET SIZE, BY MUSHROOOM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GLUCOSAMINE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTH FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GLUCOSAMINE MARKET SIZE, BY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GLUCOSAMINE MARKET SIZE, BY VETERINARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GLUCOSAMINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GLUCOSAMINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GLUCOSAMINE MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GLUCOSAMINE MARKET SIZE, BY SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY PLANT, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 329. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 330. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023